New NIH fundings to the Dulin lab for antiviral drug discovery!

The Dulin lab has been awarded funding from NIH to develop the next generation of antiviral drugs! We are part of two centers:

Rapidly Emerging Antiviral Drug Development Initiative – AViDD Center
Principal Investigator: Ralph Baric, Ph.D.
Institute: The University of North Carolina at Chapel Hill

Development of Outpatient Antiviral Cocktails against SARS-CoV-2 and other Potential Pandemic RNA Viruses
Principal Investigator: Jeffrey Glenn, M.D., Ph.D.
Institute: Stanford University School of Medicine, Stanford, California

We thank both Ralph Baric and Jeffrey Glenn for involving us in their very exciting and timely research program. We are looking forward to working with such talented group of scientists!

More information here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s